Primary hyperparathyroidism due to vitamin D deficiency

Keywords: Primary Hyperparathyroidism; Parathyroid Adenoma; Parathyroid Hormone; Hypercalcemia; Vitamin D

Abstract

Primary hyperparathyroidism is a disease that is often accompanied by hypercalcemia and can have a wide range of clinical manifestations, including atypical symptoms. One of the causes of primary hyperparathyroidism is parathyroid adenoma, the diagnosis of which is complicated by concomitant vitamin D deficiency. The aim was to analyze the diagnostic process in a patient with primary hyperparathyroidism and vitamin D deficiency, and to emphasize the importance of a multidisciplinary approach in the management of such patients. The study included a clinical case analysis of a 49-year-old patient who presented with isolated dermatological complaints. A comprehensive laboratory and instrumental examination was performed (biochemical blood test, hormonal studies, ultrasound, MRI, densitometry). Significant vitamin D deficiency (9 nmol/L), elevated parathyroid hormone (139 pg/mL), hypercalcemia (3.9 mmol/L), and decreased phosphorus were detected. A parathyroid adenoma was visualized. Initial treatment with vitamin D had little effect, confirming the primary nature of the hyperparathyroidism. The patient was referred for surgical removal of the adenoma. Therefore, primary hyperparathyroidism can mask secondary hyperparathyroidism in patients with vitamin D deficiency, which complicates diagnosis. This case highlights the importance of a comprehensive approach, including the role of an endocrinologist, surgeon, and dietitian, for timely detection and effective treatment of the disease. Surgery remains the mainstay of treatment to prevent complications, including osteoporosis and cardiovascular disorders.

References

Galani A, Morandi R, Dimko M, Molfino S at al. Atypical parathyroid adenoma: clinical and anatomical pathologic features. World J Surg Oncol. 2021 Jan 20;19(1):19. doi: 10.1186/s12957-021-02123-7. PMID: 33472651; PMCID: PMC7818751.

Palermo A, Tabacco G, Makras P, Zavatta G at al. Primary hyperparathyroidism: from guidelines to outpatient clinic. Rev Endocr Metab Disord. 2024 Oct;25(5):875-896. doi: 10.1007/s11154-024-09899-5. Epub 2024 Aug 20. PMID: 39162944.

Azar FM. Surgical Considerations for Osteoporosis, Osteopenia, and Vitamin D Deficiency. Orthop Clin North Am. 2024 Jul;55(3):xiii-xiv. doi: 10.1016/j.ocl.2024.02.004. Epub 2024 Mar 8. PMID: 38782512.

Turner, H. E., Wass, J. A. H., & Stewart, P. M. (Eds.). (2022). Oxford Textbook of Endocrinology and Diabetes (3rd ed.). Oxford University Press.

Bilezikian JP, et al. Primary Hyperparathyroidism: New Concepts in Clinical, Pathophysiological, and Therapeutic Aspects. Journal of Bone and Mineral Research, 2021.

Bandeira F, de Moura Nóbrega J, de Oliveira LB, Bilezikian J. Medical management of primary hyperparathyroidism. Arch Endocrinol Metab. 2022 Nov 11;66(5):689-693. doi: 10.20945/2359-3997000000558. PMID: 36382758; PMCID: PMC10118813.

El-Hajj Fuleihan G, Chakhtoura M, Cipriani C, Eastell R at al. Classical and Nonclassical Manifestations of Primary Hyperparathyroidism. J Bone Miner Res. 2022 Nov;37(11):2330-2350. doi: 10.1002/jbmr.4679. Epub 2022 Oct 17. PMID: 36245249.

Kochman M. Primary hyperparathyroidism: clinical manifestations, diagnosis and evaluation according to the Fifth International Workshop guidelines. Reumatologia. 2023;61(4):256-263. doi: 10.5114/reum/170705. Epub 2023 Aug 31. PMID: 37745146; PMCID: PMC10515122.

Bilezikian JP, Khan AA, Silverberg SJ, Fuleihan GE at al. International Workshop on Primary Hyperparathyroidism. Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop. J Bone Miner Res. 2022 Nov;37(11):2293-2314. doi: 10.1002/jbmr.4677. Epub 2022 Oct 17. PMID: 36245251.

Published
2025-06-29
How to Cite
1.
Yerokhovych V, Tahiieva N. Primary hyperparathyroidism due to vitamin D deficiency. USMYJ [Internet]. 2025Jun.29 [cited 2026Jun.24];154(2):103-7. Available from: https://mmj.nmuofficial.com/index.php/journal/article/view/522
Section
CLINICAL ANNUAL SCIENTIFIC EXPERIENCE (CASE)